Skip to main content
. 2019 Jan 9;53(10):886–895. doi: 10.1093/abm/kay097

Table 1.

Clinical information and demographic characteristics of the patient sample (N = 111)

n (%)
Diagnosis
 Leukemias 38 (34.2)
  CML 2 (1.8)
  CLL 3 (2.7)
  ALL 6 (5.4)
  AML 19 (17.1)
  MDS 7 (6.3)
 Lymphomas 34 (30.6)
  Hodgkin 6 (5.4)
  Non-Hodgkin 26 (23.4)
 Multiple myeloma 32 (28.8)
 Other 7 (6.3)
Graft Type
 Autologous 60 (54.1)
 Allogeneic 51 (45.9)
  Ablative, Related Donor 19 (17.1)
  Ablative, Unrelated Donor 16 (14.4)
  Non-Ablative, Related Donor 9 (8.1)
  Non-Ablative, Unrelated Donor 4 (3.6)
Sex
 Male 60 (54.1)
 Female 51 (45.9)
Ethnicity
 Caucasian 108 (97.3)
 African American 1 (.9)
 Asian American 1 (.9)
 Declined to respond 1 (.9)
Relationship Status
 Married 89 (80.2)
 Single 9 (8.1)
 Divorced/Separated 10 (9.0)
 Widowed 2 (1.8)
 Declined to respond 1 (.9)
Education
 High School or Less 25 (22.5)
 Some College/Trade School 37 (33.3)
 College Graduate 31 (27.9)
 Post-Graduate Degree 18 (16.2)
Annual Household Income
 <$25,000 4 (3.6)
 $25,001-$55,000 40 (36)
 $55,001-$85,000 30 (27)
 $85,001-$100,000 15 (13.5)
 >$100,000 17 (15.3)
 Declined to respond 5 (5.5)